Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction
Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley
Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley
View: Text | PDF
Research Article Cardiology Immunology

iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction

  • Text
  • PDF
Abstract

The role of proinflammation, and specifically TNF-α, on downstream fibrosis and healing after cardiac injury remains unknown. Using iRhom2-deficient mice, which lack myeloid-specific shedding of TNF-α, we reveal increased macrophages (MΦs) that were skewed towards a more proinflammatory (M1) state at day 4, followed by more reparative, antiinflammatory (M2) state at day 7 after myocardial infarction (MI). However, associated functional cytokine expression was significantly reduced in iRhom2-mutant M1 and M2 MΦs, respectively. A dampened proinflammatory signature in iRhom2-deficient mice during the acute phase of injury and subsequent changes in MΦ polarization were associated with reduced phagocytosis and a more sparse distribution within the scar region. This resulted in impaired collagen deposition and fibrosis, and increased left ventricular remodelling and mortality in iRhom2-deficient mice after MI. Our findings reveal a requirement for an iRhom2-mediated proinflammatory response during downstream scarring and fibrosis, which is driven in part by TNF-α signaling. These conclusions challenge the existing model that infarct repair is determined exclusively by antiinflammatory signaling of M2 MΦs, and as such we propose an alternative view of immunomodulation to maintain effective healing after infarction.

Authors

Damien N. Barnette, Thomas J. Cahill, Mala Gunadasa-Rohling, Carolyn A. Carr, Matthew Freeman, Paul R. Riley

×

Figure 9

BMDM responsiveness, polarization, and cytokine expression after exogenous TNF-α stimulation.

Options: View larger image (or click on image) Download as PowerPoint
BMDM responsiveness, polarization, and cytokine expression after exogeno...
(A) Western blotting showed that iRhom2-deficient (iRhom2–/–) bone marrow–derived macrophages (BMDMs) treated with 20 ng/ml TNF-α display activation of TNF-α downstream signaling protein phospho-NF-κB (p-NF-κB), while wild-type BMDMs displayed increased levels of p-NF-κB and p-JNK. Wild-type and iRhom2–/– samples were run in the same gel but were noncontiguous. (B) Scanning densitometry shows significant increases in p-NFκB and p-JNK relative to the loading control GAPDH. Data are shown as the mean ± SEM, n = 3 for each experimental group.*P ≤ 0.05, Student’s t test. TNF-α–stimulated iRhom2–/– BMDMs show significantly reduced (C) M1 and (D) M2 marker expression compared with controls, while (E) M1 and (F) M2 cytokine expression was partially affected. Gene expression normalized to respective stimulations without TNF-α treatment. Flow cytometric analysis of iRhom2–/– BMDMs: (G) A contour plot of the number of macrophages expressing TNFRI (MFI: 5,737 ± 59) and/or TNFRII (MFI: 14,615 ± 112) compared with wild-type BMDMs (TNFRI MFI: 3,830 ± 340; TNFRII MFI: 8,456 ± 251), and (H) biological replicates were quantified. Data are shown as the mean ± SEM, n = 4 for each experimental group. **P ≤ 0.01, 1-way ANOVA and post-hoc test. MFI, mean fluorescence intensity; TNFRI, type I TNF receptor; TNFRII, type II TNF receptor.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts